Singapore markets closed

Straits Times Index
3,306.02
+6.02(+0.18%)
Nikkei
38,596.47
-36.55(-0.09%)
Hang Seng
18,028.52
-306.80(-1.67%)
FTSE 100
8,237.72
-34.74(-0.42%)
Bitcoin USD
64,266.16
-823.93(-1.27%)
CMC Crypto 200
1,329.52
-30.80(-2.26%)

BioInvent International AB (publ) (BINV.ST)

Stockholm - Stockholm Real-time price. Currency in SEK

Add to watchlist

32.95

+0.25

(+0.76%)

At close: 05:29PM CEST

Loading interactive chart…

PR Newswire
CASI Pharmaceuticals Report Positive Interim Phase 1 Data For BI-1206 In The Treatment Of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma In China
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company specializing in the development and commercialization of innovative therapeutic and pharmaceutical products, and BioInvent International AB ("BioInvent") (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, today announced preliminary encouraging efficacy data for BI-1206 in combination with rituximab in patients